| Q33760938 | Age-dependent cerebral atrophy and cognitive dysfunction in SAMP10 mice |
| Q93606973 | Amygdala Atrophy in MCI/Alzheimer's Disease in the BIOCARD cohort based on Diffeomorphic Morphometry |
| Q35255976 | Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity |
| Q34738569 | Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort |
| Q35155378 | Automatic morphometry in Alzheimer's disease and mild cognitive impairment |
| Q57152389 | BIOMARKER CHANGE-POINT ESTIMATION WITH RIGHT CENSORING IN LONGITUDINAL STUDIES |
| Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
| Q90732347 | Effects of Age and Sex on Subcortical Volumes |
| Q48555307 | Effects of growth factors and estrogen on the development of septal cholinergic neurons from the rat. |
| Q36351414 | Hippocampal volume and shape analysis in an older adult population |
| Q30451308 | Human amygdala volume is predicted by common DNA variation in the stathmin and serotonin transporter genes |
| Q48640121 | Impaired fear conditioning in Alzheimer's disease |
| Q33947426 | Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease |
| Q34647031 | Local amygdala structural differences with 3T MRI in patients with Alzheimer disease. |
| Q30907727 | Magnetic resonance studies in Alzheimer's dementia. What routine scanning shows |
| Q36121425 | Mechanisms by Which 17β-Estradiol (E2) Suppress Neuronal cox-2 Gene Expression |
| Q52029165 | Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: an MRI volumetric and memory assessment study. |
| Q33742027 | Medial temporal atrophy in early and late-onset Alzheimer's disease |
| Q36316973 | Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study |
| Q48611181 | Morphological alterations to neurons of the amygdala and impaired fear conditioning in a transgenic mouse model of Alzheimer's disease |
| Q37054022 | Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage |
| Q61809515 | Multiparametric graph theoretical analysis reveals altered structural and functional network topology in Alzheimer's disease |
| Q60950956 | Multivariate Deep Learning Classification of Alzheimer's Disease Based on Hierarchical Partner Matching Independent Component Analysis |
| Q34489952 | Network Neurodegeneration in Alzheimer's Disease via MRI Based Shape Diffeomorphometry and High-Field Atlasing |
| Q50048402 | Neurogranin as a predictor of memory and executive function decline in MCI patients |
| Q48583975 | Neuronal changes in the basolateral complex during development of the amygdala of the rat. |
| Q52172749 | Neuronal loss and beta-amyloid removal in the amygdala of people with Down syndrome. |
| Q34669762 | Nodular bilateral amygdala degeneration in demented individuals |
| Q39784495 | One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial. |
| Q30503658 | Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease |
| Q36234023 | Preserved and impaired emotional memory in Alzheimer's disease |
| Q48866108 | Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex |
| Q48656545 | Recognition memory for emotional pictures in Alzheimer's patients |
| Q46189364 | Regional atrophy of the corpus callosum in dementia |
| Q43959480 | Regional specificity of sex effects on subcortical volumes across the lifespan in healthy aging. |
| Q40882851 | Removing inter-subject technical variability in magnetic resonance imaging studies |
| Q33735332 | SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele |
| Q35759912 | Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting |
| Q46251905 | The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases |
| Q34441061 | The cholinergic system in Alzheimer's disease |
| Q37393743 | The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease |
| Q42490648 | The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies |
| Q74372213 | The human amygdala: a systematic review and meta-analysis of volumetric magnetic resonance imaging |
| Q48971968 | The importance of accurate anatomic assessment for the volumetric analysis of the amygdala |
| Q42518169 | Types of neurons and some dendritic patterns of basolateral amygdala in humans--a golgi study |
| Q52020877 | Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions |